🇺🇸 FDA
Pipeline program

OPB-31121

252-07-801-01

Phase 1 small_molecule completed

Quick answer

OPB-31121 for Non-Hodgkin's Lymphoma(NHL) is a Phase 1 program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
Otsuka Beijing Research Institute
Indication
Non-Hodgkin's Lymphoma(NHL)
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials